FKnol.com

Financial Knowledge & Information Portal

Best Performing Biotech Stocks of 2020

Updated Sep 15, 2020
Biotech, or biotechnology, is defined as the exploitation and use of biological processes for industrial, commercial and other requirements, especially the genetic manipulation of microorganisms for the generation, production and development of medicinal elements like antibiotics and hormones which can be used for therapeutic use. It is the technology that uses biological systems, living organisms or their parts to build and develop different products. The specialized sub-sector falls within the larger health care sector and involves activities like drug development, research, manufacturing and marketing in the field of biotech.
Among the big basket of Biotech stocks, which ones generated the top returns this year? Which of those figured among the winners in the long list of Biotech stocks?
This article provides a list of Biotech stocks which have generated the highest returns in the year 2020 so far. till date of writing. The list is prepared based on the percentage returns generated by the individual Biotech stocks between the end of the previous year and Sep 15, 2020, and the top 10 return generating Biotech stocks are listed below.
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.

Top Performing Biotech StocksAll Biotech StocksAll Biotech ETFsTop Dividend-paying Biotech StocksTop Biotech Stocks for Q4 2020

Top Biotech Stocks With Highest Returns

The following list presents stocks of the companies which belong to the broader Biotech sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized:
 1) Novavax, Inc. (NVAX) 2) Vaxart, Inc. (VXRT) 3) Trillium Therapeutics Inc. (TRIL) 4) Genprex, Inc. (GNPX) 5) Adaptimmune Therapeutics plc (ADAP)
 6) iBio, Inc. (IBIO) 7) Seres Therapeutics, Inc. (MCRB) 8) Altimmune, Inc. (ALT) 9) Kitov Pharmaceuticals Holdings Ltd. (KTOV) 10) Celldex Therapeutics, Inc. (CLDX)
There's more... See price performance, YTD-gains, market-cap and other details of all the 491 Biotech stocks with sorting features in a tabular format. Alternatively, one can also explore the List of Top Biotech ETFs.

Try our new Best Performing Stock Screener:

Top Performing Biotech StocksAll Biotech StocksAll Biotech ETFsTop Dividend-paying Biotech StocksTop Biotech Stocks for Q4 2020

Performance of Top Biotech Stocks

Here's a look at the basic details and how the above mentioned stocks fared during the period:

Novavax

Novavax, Inc. (Novavax), incorporated on June 18, 1987, is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Novavax.
The Maryland, MD-headquartered company Novavax, Inc. (NVAX) is ranked number one among the best performing stocks of Biotech of 2020. The Health Care sector business falls under the Biotech Biological Products industrial sub-sector. Since the start of the year 2020, the stock price of Novavax has changed by 2672.36 percent, which is calculated based on the previous year's closing price of $3.98 per share and year-to-date closing price of $110.34 per share as of writing. The market value of the company as indicated by its market-cap changed from $105.78 million to $6.76 billion during the same period. Along with Biotech, the company is also in the business of Health Care, Biotech Biological Products, Biotech Products, Biotechnology, Healthcare, Wilshire 5000, Russell 2000, among other usual products and services. Novavax continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, Russell 2000 index, and a few other larger indexes which are part of the stock market.

Vaxart

Vaxart, Inc., a clinical-stage company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus. It is also developing therapeutic immune-oncology vaccines ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Vaxart.
During the given months of the year 2020, Vaxart, Inc. (VXRT) was successful in generating YTD returns of 1757.14 percentage which helped it gain the number two spot in the list of the top performing stocks which generated maximum returns during year 2020 till date. As of December of the previous year, the stock of the USA-based Vaxart closed at a price of $0.35 per share, while it traded at a price of $6.5 per share as of Sep 15, 2020. The company's market cap changed from $17.09 million to $753.49 million during the same period YTD. It ranks as a key constituent of major indexes that include Wilshire 5000 index, Russell 2000 index, and several other broader level multi-cap market indicators. The company is classified under the Health Care industry sector and further specialized as a Healthcare sector business.

Trillium Therapeutics

Trillium Therapeutics Inc., a clinical-stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced hematologic malignancies, and solid ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Trillium Therapeutics.
Rank number three in the coveted list is held by Trillium Therapeutics Inc. (TRIL) for being among the top performing stocks of 2020. Headquartered in Canada, the Health Care sector company is categorized under the industrial sub-sector of Major Pharmaceuticals. Since the start of the year 2020, stock of Trillium Therapeutics has so far gained 1324.27 percentage, based on the previous year's closing price of $1.03 per share and year-to-date price of $14.67 per share. During the same period, the market capitalization of the company changed from $28.62 million to $1.27 billion.

Genprex

Genprex, Inc., a clinical-stage gene therapy biotechnology company, develops immunogene therapy products for treating cancer. Its lead drug candidate is Oncoprex, which is in Phase II clinical trials for the tr ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Genprex.
At number four in the list of top stocks stands Genprex, Inc. (GNPX), which saw a change in its stock price from the level of $0.32 apiece during previous year December end to the price of $3.78 per share as of Sep 15, 2020. It translates to a change of 1081.25 percentage. The Austin, TX-headquartered Health Care sector company also saw its market value change from $6.16 million to $146.93 million. The Healthcare specialist also managed to outperform some of the major stock market indexes of which it is a part of. They include the Russell 2000 index, and a handful of other multi-capitalization indexes.

Adaptimmune Therapeutics

Adaptimmune Therapeutics plc, incorporated on December 03, 2014, is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Adaptimmune Therapeutics.
The United Kingdom-based Health Care sector company Adaptimmune Therapeutics plc (ADAP) holds the number five spot among the best performing stocks of the Biotech sector. Classified as the Biotech Biological Products business, the stock price of Adaptimmune Therapeutics ended the previous year at a price of $1.2 per share while it reached the level of $10.08 apiece as of Sep 15, 2020 translating to a percentage change in stock price of 740%. As of writing, the company's market-cap value stands at $1.56 billion.

iBio

iBio, Inc., incorporated on April 17, 2008, is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of iBio.
iBio, Inc. (IBIO) has moved by 704 percentage over the given period of 2020-YTD, helping it gain a place at number six among the top performing stocks. The Health Care sector company managed to achieve the feat as its stock price changed from $0.25 apiece to the price of $2.01 per share between the end of December of the previous year and Sep 15, 2020. The smart run of the Delaware, DE-based Major Pharmaceuticals sector company lead to a handsome gain in its marketcap which changed from $7.95 million to $350.57 million over the same duration. iBio is a key member of many popular stock market indexes. They include Wilshire 5000 index, Russell 2000 index, and several other broader level multi-cap market indicators.

Seres Therapeutics

Seres Therapeutics, Inc., incorporated on October 18, 2010, is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Seres Therapeutics.
The number seven spot in the list of top performing stocks of the Biotech sector is taken by Seres Therapeutics, Inc. (MCRB). The company's stock price changed from $3.45 per share at the end of December of the previous year to the price of $27.32 per share as of writing. Overall, the stock managed to realized price change of 691.88 percent during the given time period. The corresponding change in the market capitalization value of the Massachusetts, MA-based Health Care sector company was from $256.94 million to $2.44 billion. Being ranked in the top 10 best performing stocks of the Biotech sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes. They include the Wilshire 5000 index, Russell 2000 index, and a handful of other multi-capitalization indexes.

Altimmune

Altimmune, Inc., a clinical stage immunotherapeutic biotechnology company, focuses on discovering and developing immunotherapies and vaccines to address the unmet medical needs. The company develops NasoVAX, an ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Altimmune.
Altimmune (ALT) generated percentage returns of 558.73 percent during the 2020 year-to-date. Its returns are based on the share price which moved from $1.89 per share from the previous year-end to the price of $12.45 per share as of Sep 15, 2020. The company's value, as indicated by the market-cap figure, changed from $28.99 million to $409.75 million during the same period.
The company is categorized as a Health Care speciality business with further classification in the Healthcare sub-category. Based in Gaithersburg, MD, the YTD performance of the Biotech sector also fared better than that of the returns generated by some of the closley tracked stock market indexes. The company is a part of Wilshire 5000 index, and a few other wider multi-cap stock market indexes.

Kitov Pharma

Kitov Pharma Ltd, through its subsidiaries, operates as a development stage biopharmaceutical company in Israel. It develops combination drugs for the simultaneous treatment of pain caused by osteoarthritis and ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Kitov Pharma.
The Tel Aviv, -based Kitov Pharmaceuticals Holdings Ltd. (KTOV) belongs to the Health Care sector and is categorized as a Major Pharmaceuticals company. The stock of Kitov Pharma ended the previous year at a price of $0.77 per share. As of Sep 15, 2020, the stock price has reached $4.34 apiece, which indicates a change of 463.64 percent making the company rank among the top performing stocks of the Biotech for the year 2020 till date. At the end of the last year, company's market capitalization stood at $14.54 million. It has now changed to $74.19 million as of writing.

Celldex Therapeutics

Celldex Therapeutics, Inc., incorporated on December 9, 1983, is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Celldex Therapeutics.
Based on the market-cap change from $37.27 million to $503.36 million during the given months of the year 2020 and the share price change from $2.23 per share to a price of $11.73 per share as of Sep 15, 2020, Celldex Therapeutics, Inc. (CLDX) was successful in generating YTD returns of 426.01 percentage. Standing at the number ten rank in the top performing list of Biotech stocks, the Massachusetts, MA-based Celldex Therapeutics is categorized as the Biotech In Vitro In Vivo Diagnostics sub-sector business which falls under the larger Health Care sector. It is also a part of few famous stock indexes that are used to track the overall performance of the stock market. They include Wilshire 5000 index, and a few more broader-level indexes that are actively tracked in the market.
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.

Popular Investment Lists:

 ◐ Best Performing S&P 500 Stocks of 2020-YTD

 ◐ Best Performing Dow Jones Stocks of 2020-YTD

 ◐ Best Performing NASDAQ Stocks of 2020-YTD

 ◐ Best Performing Russell 2000 Stocks of 2020-YTD

 ◐ Best Performing Wilshire 5000 Stocks of 2020-YTD

 ◐ Top U.S. Companies By Market Value of 2020

 ◐ Best Performing Mega Cap Stocks of 2020-YTD

 ◐ Best Performing Large Cap Stocks of 2020-YTD

 ◐ Best Performing Mid Cap Stocks of 2020-YTD

 ◐ Best Performing Small Cap Stocks of 2020-YTD

 ◐ Best Performing Micro Cap Stocks of 2020-YTD

 ◐ Best Performing Real Estate Stocks of 2020-YTD

 ◐ Best Performing Mortgage REITs of 2020-YTD

 ◐ Best Performing Diversified REITs of 2020-YTD

 ◐ Best Performing Residential REITs of 2020-YTD

 ◐ Best Performing Office REITs of 2020-YTD

 ◐ Best Performing Retail REITs of 2020-YTD

 ◐ Best Performing Hotel REITs of 2020-YTD

 ◐ Best Performing Industrial REITs of 2020-YTD

 ◐ Best Performing Healthcare REITs of 2020-YTD

 ◐ Market Cap of S&P 500 Companies of 2020

 ◐ Market Cap of NASDAQ 100 Companies of 2020

 ◐ Market Cap of Dow Jones (DJIA) Companies of 2020

 ◐ Best Performing Hedge Fund Stocks of 2020-YTD

 ◐ Best Performing Conglomerates Stocks of 2020-YTD

 ◐ Best Performing Diversified Commercial Services Stocks of 2020-YTD

 ◐ Best Performing Diversified Industrials Stocks of 2020-YTD

 ◐ Best Performing Diversified Insurance Stocks of 2020-YTD

 ◐ Best Performing Diversified Utilities Stocks of 2020-YTD

 ◐ Best Performing Multi-sector Companies of 2020-YTD

 ◐ Best Performing Miscellaneous Stocks of 2020-YTD

 ◐ Best Performing Miscellaneous Manufacturing Stocks of 2020-YTD

 ◐ Best Performing Natural Gas Stocks of 2020-YTD

 ◐ Best Performing Silver Stocks of 2020-YTD

 ◐ Best Performing Gold Stocks of 2020-YTD

 ◐ Best Performing Technology Stocks of 2020-YTD

 ◐ Best Performing Cannabis Stocks of 2020-YTD

 ◐ Best Performing Consumer Discretionary Stocks of 2020-YTD

 ◐ Best Performing Cloud Computing Stocks of 2020-YTD

 ◐ Best Performing Oil Stocks of 2020-YTD

 ◐ Best Performing Food & Beverage Stocks of 2020-YTD

 ◐ Best Performing 'SMALL' Dogs of the Dow of 2020-YTD

 ◐ Best Performing Low Beta Stocks of 2020-YTD

 ◐ Best Performing Dividend Aristocrats Stocks of 2020-YTD

 ◐ Best Performing High Beta Stocks of 2020-YTD

 ◐ Best Performing Basic Materials Stocks of 2020-YTD

 ◐ Best Performing Basic Industries Stocks of 2020-YTD

 ◐ Best Performing Healthcare Stocks of 2020-YTD

 ◐ Best Performing Pharma Stocks of 2020-YTD

 ◐ Best Performing Private Equity Stocks of 2020-YTD

 ◐ Best Performing ESG Stocks of 2020-YTD

 ◐ Best Performing Semiconductors Stocks of 2020-YTD

 ◐ Best Performing Brazil Stocks of 2020-YTD

 ◐ Best Performing Robotics Stocks of 2020-YTD

 ◐ Best Performing Tobacco Stocks of 2020-YTD

 ◐ Best Performing Fast Food Stocks of 2020-YTD

 ◐ Best Performing Coffee Stocks of 2020-YTD

 ◐ Best Performing Newspaper Stocks of 2020-YTD

 ◐ Best Performing Transportation Stocks of 2020-YTD

 ◐ Best Performing Precious Metals Stocks of 2020-YTD

 ◐ Best Performing Mexican Stocks of 2020-YTD

 ◐ Best Performing Indian Stocks of 2020-YTD

 ◐ Best Performing Renewable Energy Stocks of 2020-YTD

 ◐ Best Performing Russia Stocks of 2020-YTD

 ◐ Best Performing Water Stocks of 2020-YTD

 ◐ Best Performing Agriculture Stocks of 2020-YTD

 ◐ Best Performing Airlines Stocks of 2020-YTD

 ◐ Best Performing Blockchain Stocks of 2020-YTD

 ◐ Best Performing Natural Resources Stocks of 2020-YTD

 ◐ Best Performing Internet Stocks of 2020-YTD

 ◐ Best Performing Bank Stocks of 2020-YTD

 ◐ Best Performing Meat Stocks of 2020-YTD

 ◐ Best Performing Gaming Stocks of 2020-YTD

 ◐ Best Performing Biofuels Stocks of 2020-YTD

 ◐ Best Performing Software Stocks of 2020-YTD

 ◐ Best Performing China Stocks of 2020-YTD

 ◐ Best Performing Telecom Stocks of 2020-YTD

 ◐ Best Performing Biotech Stocks of 2020-YTD

 ◐ Best Performing Aluminum Stocks of 2020-YTD

 ◐ Best Performing Low Volatility Stocks of 2020-YTD

 ◐ Best Performing REIT Stocks of 2020-YTD

 ◐ Best Performing 5G Stocks of 2020-YTD

 ◐ Best Performing Dogs of the Dow Stocks of 2020-YTD

 ◐ Best Performing Palladium Stocks of 2020-YTD

 ◐ Best Performing Platinum Stocks of 2020-YTD

 ◐ Best Performing Iron Stocks of 2020-YTD

 ◐ Best Performing Steel Stocks of 2020-YTD

 ◐ Market Cap of TSX Composite Index Companies of 2020

 ◐ Market Cap of TSX 60 Index Companies of 2020

 ◐ Market Cap of TSX Venture Composite Index Companies of 2020

 ◐ Market Cap of ASX 50 Index Companies of 2020

 ◐ Market Cap of ASX 200 Index Companies of 2020

 ◐ Market Cap of All Ordinaries Index Companies of 2020

 ◐ See All Common Lists

 Search This Site